To Compare effects of Levobupivacaine with Ropivacaine(Isobaric) and Levobupivacaine in abdominal Hysterectomy

Study to Compare Effects of Levobupivacaine Heavy with Ropivacaine(Isobaric) and Levobupivacaine Heavy in Patients Posted for Abdominal Hysterectomy(Two Drug Technique) - Nill

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/081511

Enrollment

120

Registered

2025-03-03

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N72- Inflammatory disease of cervix uteri

Interventions

Intervention1: Levobupivacaine (Heavy): 2.5ml (12.5mg) of hyperbaric levobupivacaine 0.5% and 25 mcg fentanyl at L3-L4 Space Intrathecally, once at time of induction of the case Control Intervention

Eligibility

Inclusion criteria

Inclusion criteria: 1 Gynecologic indication like Fibroid, Abnormal Uterine Bleeding, Adenomyoma etc. 2 Body weight 50kg to 90 kg 3 Height 150 cm to 170 cm

Exclusion criteria

Exclusion criteria: 1 ASA IV 2 Emergency 3 Uncontrolled Diabetes and Hypertension 4 Chronic Renal Disease 5 Anemia 6 IHD or other Cardiac Disease

Design outcomes

Primary

Measure	Time frame
Hemodynamic StabilityTimepoint: AT Baseline, 6 Hours, 12 Hours	—

Secondary

Measure	Time frame
Need of Rescue Analgesia measured by Verbal Rating ScaleTimepoint: 12 hours and 24 hours	—

Countries

India

Contacts

Public ContactDr Sunit Kumar

Government Medical College Jalaun(Orai)

sunit.sachan@gmail.com9532456809

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026